D

24782 publications

1. Drug Discovery and Evaluation
2. Drug Discovery and Evaluation
3. Drug Discovery and Evaluation
4. Drug Discovery and Evaluation
5. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
6. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
7. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
8. Drug Discovery and Evaluation: Pharmacological Assays
9. Drug Discovery and Evaluation: Pharmacological Assays
10. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
11. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
12. Drug Discovery and Traditional Chinese Medicine
13. Drug Discovery from Mother Nature
14. Drug Discovery in Africa
15. Drug Discovery in Japan
16. Drug Discovery in Pancreatic Cancer
17. Drug Dosage in Renal Insufficiency
18. Drug Dosing in Obesity
19. Drug Education in Schools
20. Drug Epidemiology / Pharmako-Epidemiologie
21. Drug Epidemiology and Post-Marketing Surveillance
22. Drug Eruptions
23. Drug Evaluation in Angina Pectoris
24. Drug Interactions in Infectious Diseases
25. Drug Interactions in Infectious Diseases
26. Drug Interactions in Infectious Diseases
27. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions
28. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions
29. Drug Legalization
30. Drug Management of Prostate Cancer
31. Drug Metabolism
32. Drug Metabolism and Pharmacokinetics Quick Guide
33. Drug Metabolism and Transport
34. Drug Metabolite Isolation and Determination
35. Drug Misuse
36. Drug Misuse and the Law
37. Drug Mules
38. Drug Policies and the Politics of Drugs in the Americas
39. Drug Policy Harmonization and the European Union
40. Drug Policy and Human Nature
41. Drug Product Development for the Back of the Eye
42. Drug Receptor Interactions in Antimicrobial Chemotherapy
43. Drug Receptors
44. Drug Receptors and Their Effectors
45. Drug Repurposing
46. Drug Repurposing for Emerging Infectious Diseases and Cancer
47. Drug Research and Drug Development in the 21st Century
48. Drug Resistance
49. Drug Resistance in Bacteria, Fungi, Malaria, and Cancer
50. Drug Resistance in Cancer Cells
51. Drug Resistance in Cancer Therapy
52. Drug Resistance in Cancer: Mechanisms and Strategies
53. Drug Resistance in Leishmania Parasites
54. Drug Resistance in Leishmania Parasites
55. Drug Resistance in Leukemia and Lymphoma III
56. Drug Safety Evaluation
57. Drug Safety Evaluation
58. Drug Safety in Clinical Practice
59. Drug Stability and Chemical Kinetics
60. Drug Studies in the Elderly
61. Drug Target Selection and Validation
62. Drug Target miRNA
63. Drug Targeting
64. Drug Targets for Plasmodium Falciparum: Historic to Future Perspectives
65. Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
66. Drug Targets in Kinetoplastid Parasites
67. Drug Testing in Alternate Biological Specimens
68. Drug Testing in the Workplace
69. Drug Therapy and Interactions in Pediatric Oncology
70. Drug Therapy for Type 2 Diabetes
71. Drug Therapy for the Elderly
72. Drug Toxicity in Embryonic Development I
73. Drug Toxicity in Embryonic Development II
74. Drug Transporters
75. Drug Transporters in Drug Disposition, Effects and Toxicity
76. Drug Treatment Courts
77. Drug Treatment in Obstetrics
78. Drug Treatment in Obstetrics
79. Drug Treatment of Sleep Disorders
80. Drug Use Trajectories Among Minority Youth
81. Drug Use and Ethnicity in Early Adolescence
82. Drug Use and Social Change
83. Drug Use in Pregnancy: Mother and Child
84. Drug Users in Society
85. Drug and Alcohol Abuse
86. Drug and Alcohol Abuse
87. Drug and Alcohol Abuse
88. Drug and Alcohol Abuse
89. Drug and Alcohol Abuse
90. Drug and Alcohol Abuse
91. Drug and Alcohol Abuse Prevention
92. Drug and Alcohol Use
93. Drug and Biological Development
94. Drug and Gene Delivery to the Central Nervous System for Neuroprotection
95. Drug-Coated Balloons
96. Drug-DNA Interaction Protocols
97. Drug-DNA Interaction Protocols
98. Drug-Induced Headache
99. Drug-Induced Hepatotoxicity
100. Drug-Induced Injury to the Digestive System
101. Drug-Induced Liver Toxicity
102. Drug-Induced Lung Injury
103. Drug-Induced Oral Complications
104. Drug-Induced Pathology
105. Drug-induced Neurological Disorders
106. Drug-related problems in the elderly
107. Druggable Lipid Signaling Pathways
108. Drugs Affecting Growth of Tumours
109. Drugs Affecting Leukotrienes and Other Eicosanoid Pathways
110. Drugs Affecting Lipid Metabolism
111. Drugs Affecting Lipid Metabolism
112. Drugs Affecting Lipid Metabolism
113. Drugs Affecting Lipid Metabolism VIII
114. Drugs Compromising Male Sexual Health
115. Drugs During Pregnancy
116. Drugs Easily Explained
117. Drugs Eicosanoids
118. Drugs Handbook 1988–9
119. Drugs Handbook 1989–1990
120. Drugs Handbook 1990–1991
121. Drugs Handbook 1991–92
122. Drugs Handbook 1992–93
123. Drugs Handbook 1993-94
124. Drugs Handbook 1994–95
125. Drugs Handbook 1995–96
126. Drugs Handbook 1996–97
127. Drugs Looking for Diseases
128. Drugs Targeting B-Cells in Autoimmune Diseases
129. Drugs and Aging
130. Drugs and Alcohol
131. Drugs and Central Synaptic Transmission
132. Drugs and Child Maltreatment
133. Drugs and Fetal Development
134. Drugs and Human Behavior
135. Drugs and Immune Responsiveness
136. Drugs and Poisons in Humans
137. Drugs and Public Health in Post-Soviet Central Asia
138. Drugs and Social Context
139. Drugs and Transport Processes
140. Drugs and a Methodological Compendium
141. Drugs and the Addiction Aesthetic in Nineteenth-Century Literature
142. Drugs and the Developing Brain
143. Drugs and the Elderly
144. Drugs and the Inheritance of Behavior
145. Drugs and the Kidney
146. Drugs and the Liver: High Risk Patients and Transplantation
147. Drugs and the Lung
148. Drugs as Tools in Neurotransmitter Research
149. Drugs between Research and Regulations
150. Drugs en alcohol; Gebruik, misbruik en verslaving
151. Drugs for HER-2-positive Breast Cancer
152. Drugs for Heart Disease
153. Drugs for Relapse Prevention of Alcoholism
154. Drugs for the Treatment of Parkinson’s Disease
155. Drugs from Nature: Targets, Assay Systems and Leads
156. Drugs in Adolescent Worlds
157. Drugs in Adolescent Worlds
158. Drugs in Africa
159. Drugs in Breast Milk
160. Drugs in Current Use 1958
161. Drugs in Ophthalmology
162. Drugs in South Asia
163. Drugs in the Management of Heart Disease
164. Drugs of Abuse
165. Drugs of Abuse
166. Drugs of Abuse
167. Drugs of Abuse, Immunity, and AIDS
168. Drugs of Abuse, Immunity, and Immunodeficiency
169. Drugs of Abuse, Immunomodulation, and Aids
170. Drugs on the Dark Net: How Cryptomarkets are Transforming the Global Trade in Illicit Drugs
171. Drugs, Alcohol, Pregnancy and Parenting
172. Drugs, Athletes, and Physical Performance
173. Drugs, Crime and Corruption
174. Drugs, Crime, and Other Deviant Adaptations
175. Drugs, Driving and Traffic Safety
176. Drugs, Gangs, and Violence
177. Drugs, Identity and Stigma
178. Drugs, Lipid Metabolism, and Atherosclerosis
179. Drugs, Neurotransmitters, and Behavior
180. Drugs, Neurotransmitters, and Behavior
181. Drugs, Prisons and Policy-Making
182. Drugs, Systemic Diseases, and the Kidney
183. Drugs, Violence and Latin America
184. Drug∼Nutrient Interactions
185. Drunk on Capitalism. An Interdisciplinary Reflection on Market Economy, Art and Science
186. Drupal 8 for Absolute Beginners
187. Dry Clutch Control for Automotive Applications
188. Dry Etching Technology for Semiconductors
189. Dry Etching for VLSI
190. Dry Eye
191. Dry Fish: A Global Perspective on Nutritional Security and Economic Sustainability
192. Dry Gross Fretting of Rough Surfaces
193. Dry Mineral Processing
194. Dry Mouth
195. Dry Scrubbing Technologies for Flue Gas Desulfurization
196. Dry Zones
197. Drying Kinetics in Building Materials and Components
198. Drying and Energy Technologies
199. Drying and Wetting of Building Materials and Components
200. Drying of Polymeric and Solid Materials